WO2002062982A1 - Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications - Google Patents

Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications Download PDF

Info

Publication number
WO2002062982A1
WO2002062982A1 PCT/CN2001/000115 CN0100115W WO02062982A1 WO 2002062982 A1 WO2002062982 A1 WO 2002062982A1 CN 0100115 W CN0100115 W CN 0100115W WO 02062982 A1 WO02062982 A1 WO 02062982A1
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
gene
cell immune
specific
cell
Prior art date
Application number
PCT/CN2001/000115
Other languages
English (en)
Chinese (zh)
Inventor
Kamfu Wong
Original Assignee
Six Forest Bio-Science Institute Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Six Forest Bio-Science Institute Limited filed Critical Six Forest Bio-Science Institute Limited
Priority to PCT/CN2001/000115 priority Critical patent/WO2002062982A1/fr
Publication of WO2002062982A1 publication Critical patent/WO2002062982A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Landscapes

  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention porte sur un procédé faisant appel à des informations relatives à des ondes bioélectriques de simulation consistant à activer un gène récessif de levure normale et à la transformer en levure spécifique, les protéines spécifiques (enzymes) exprimées par la levure spécifique présentant la fonction d'activation, de régulation et de correction de gènes immunitaires de lymphocytes B, de gènes immunitaires de lymphocytes T, de gènes immunitaires de lymphocytes K et de gènes allèles de lymphocytes NK à faible compétence immunologique. La levure spécifique sous forme de préparation biologique permet de réguler le gène immunitaire du corps afin de rétablir les fonctions immunitaires du corps et de soigner le patient. Les préparations biologiques peuvent être appliquées dans le traitement de différentes maladies, notamment les tumeurs, l'urémie, l'hépatite, la démence sénile, les maladies gastro-intestinales, le diabète, et les troubles du système nerveux. Cette préparation est très efficace, sans effets toxiques ou secondaires.
PCT/CN2001/000115 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications WO2002062982A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000115 WO2002062982A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000115 WO2002062982A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications

Publications (1)

Publication Number Publication Date
WO2002062982A1 true WO2002062982A1 (fr) 2002-08-15

Family

ID=4574769

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000115 WO2002062982A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications

Country Status (1)

Country Link
WO (1) WO2002062982A1 (fr)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375651A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour l'activation et la prolifération des globules blancs
EP1375652A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour des sujets infectés par le VIH
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (fr) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition destinée au traitement de maladies ou de troubles neurodégénératifs, méthode et utilisation impliquant de la levure électromagnétiquement irradiée

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09182582A (ja) * 1996-01-05 1997-07-15 Kagaku Gijutsu Shinko Jigyodan 細胞培養法と細胞培養装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09182582A (ja) * 1996-01-05 1997-07-15 Kagaku Gijutsu Shinko Jigyodan 細胞培養法と細胞培養装置

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DING ZHISHAN ET AL.: "Transforming yeast bioplast by ultrasonic-method", BIOTECHNOLOGY, vol. 6, no. 4, 1996, pages 41 - 43 *
GAO DAWEI ET AL.: "Effects of linear ultrasonic wave irradiation on the growth of saccharomyces cerevisiae", JOURNAL OF SOUTH CHINA UNIVERSITY OF TECHNOLOGY (NATURAL SCIENCE), vol. 27, no. 12, December 1999 (1999-12-01), pages 34 - 37 *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375651A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour l'activation et la prolifération des globules blancs
EP1375652A3 (fr) * 2002-06-28 2004-01-07 Ultra Biotech Limited Composition orale pour des sujets infectés par le VIH
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (fr) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition destinée au traitement de maladies ou de troubles neurodégénératifs, méthode et utilisation impliquant de la levure électromagnétiquement irradiée
CN102481368A (zh) * 2009-08-26 2012-05-30 密美德有限公司 包含电磁辐射的酵母的治疗神经变性疾病或病症的组合物、方法和用途
JP2013503138A (ja) * 2009-08-26 2013-01-31 エムビー ミルメド エービー 電磁放射酵母を含む神経変性疾患または障害の処置のための組成物、方法および使用
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Similar Documents

Publication Publication Date Title
WO2002062982A1 (fr) Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications
WO2002062984A1 (fr) Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications
WO2004039956A3 (fr) Compositions et methodes de traitement de maladies liees au systeme immunitaire
WO2002062983A1 (fr) Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications
WO2002062985A1 (fr) Levure faisant preuve d'un activite immunoregulatrice cellulaire nk, son procede de preparation et ses applications
WO2005037257A3 (fr) Nouveaux inhibiteurs d'alanyl-aminopeptidases destines a exercer une influence fonctionnelle sur diverses cellules et a constituer un traitement immunologique de maladies inflammatoires, neuronales et autres
WO2002062981A1 (fr) Immunoregulateur humain de levure et son procede de preparation
WO2005019258A3 (fr) Compositions et methodes de traitement de maladies relatives au systeme immunitaire
WO2003033720A8 (fr) Proteine a base de variants de tnf-alpha pour le traitement de troubles associes au tnf-alpha
WO2003030927A3 (fr) Utilisation de peptides analogues de la thymuline (pat) pour la fabrication de medicaments contre la douleur
WO2005058945A3 (fr) Variants genetiques codant pour des proteines issues de la voie metabolique de produits chimiques fins
WO1997011667A3 (fr) Utilisation therapeutique de serums d'animaux, en particulier du cheval, pour le traitement du sida, du cancer et d'autres maladies virales et bacteriennes
WO2004009024A3 (fr) Modulation de l'expression de la proteine kinase c-iota
WO2002062946A3 (fr) Identification de nouveaux membres de la famille de gene ms4a exprimes par des cellules hematopoietiques
WO2005033145A8 (fr) Anticorps diriges contre nik, preparation et emploi
WO2002101068A3 (fr) Procede de preparation de l'acide d-pantothenique et/ou de ses sels
AU2002358488A1 (en) Alleles of the glucokinase gene coryneform bacteria
AU2001292310A1 (en) Method of regulating the activity of expression product of gene transferred intoliving body
WO2007092609A3 (fr) Procede de traitement de maladie arterielle peripherique par proteines a doigts de zinc
WO2004043397A3 (fr) Compositions et procedes pour le traitement de la polyarthrite rhumatoide
WO2007044912A3 (fr) Osteopontine active constitutive non native
WO2003019146A3 (fr) Essais de criblage a haut rendement mettant en oeuvre des enzymes synthetiques d'acide gras
WO2002022631A3 (fr) Regulation d'une enzyme de type pyroglutamyl peptidase humaine
WO2004004649A3 (fr) Compositions et procedes destines au traitement de maladies liees au systeme immunitaire
WO2002000853A3 (fr) Regulation de la protease de type caspase 1 humaine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP